Surgery Historical Financial Ratios

SGRY Stock

USD 21.55 0.70 3.15%

Surgery Partners is promptly reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 25.29, Free Cash Flow Yield of 0.065, Invested Capital of 0.0 or Operating Cash Flow Per Share of 1.73 will help investors to properly organize and evaluate Surgery Partners financial condition quickly.

Quick Ratio Current Ratio

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgery Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

About Surgery Financial Ratios Analysis

Surgery PartnersFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Surgery Partners investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Surgery financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Surgery Partners history.

Surgery Partners Financial Ratios Chart

At this time, Surgery Partners' POCF Ratio is fairly stable compared to the past year. Payout Ratio is likely to rise to 0.07 in 2024, whereas Dividend Yield is likely to drop 0 in 2024.

Price To Sales Ratio Dividend Yield Days Sales Outstanding Free Cash Flow Yield

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Surgery Partners stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Surgery Partners sales, a figure that is much harder to manipulate than other Surgery Partners multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Surgery Partners dividend as a percentage of Surgery Partners stock price. Surgery Partners dividend yield is a measure of Surgery Partners stock productivity, which can be interpreted as interest rate earned on an Surgery Partners investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Most ratios from Surgery Partners' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Surgery Partners current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgery Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.At this time, Surgery Partners' POCF Ratio is fairly stable compared to the past year. Payout Ratio is likely to rise to 0.07 in 2024, whereas Dividend Yield is likely to drop 0 in 2024.

	2023	2024 (projected)
Dividend Yield	0.001516	0.00144
Price To Sales Ratio	1.46	1.52

Dividend Yield Price To Sales Ratio

Surgery Partners fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		0.93	0.0	0.34	-0.94	-0.6	-0.73	-0.67	0.0	0.91	-0.52	0.63	0.47	0.2	-0.13	-0.79	-0.69	-0.63	0.52	0.63	-0.91	-0.54	0.21	0.67	-0.18	0.13
Dividend Yield	0.93		0.0	0.42	-0.99	-0.38	-0.66	-0.64	0.0	0.9	-0.43	0.61	0.47	-0.03	-0.07	-0.76	-0.71	-0.67	0.36	0.48	-0.94	-0.63	0.01	0.71	-0.13	0.09
Ptb Ratio	0.0	0.0		0.04	0.0	0.14	0.07	-0.18	1.0	0.01	0.11	0.71	0.03	-0.02	-0.01	0.01	-0.13	0.14	0.03	0.08	0.01	-0.07	0.04	0.01	0.09	0.61
Days Sales Outstanding	0.34	0.42	0.04		-0.47	-0.32	-0.46	-0.23	0.04	0.68	-0.34	0.25	-0.6	-0.19	0.86	-0.74	-0.34	-0.21	0.58	-0.21	-0.11	-0.06	0.32	0.9	-0.05	0.2
Book Value Per Share	-0.94	-0.99	0.0	-0.47		0.44	0.68	0.63	0.0	-0.93	0.46	-0.63	-0.4	-0.01	0.0	0.81	0.69	0.69	-0.41	-0.49	0.92	0.61	-0.05	-0.76	0.14	-0.12
Free Cash Flow Yield	-0.6	-0.38	0.14	-0.32	0.44		0.72	0.07	0.14	-0.61	0.74	-0.35	0.01	-0.69	-0.18	0.59	0.0	0.41	-0.75	-0.45	0.32	-0.24	-0.6	-0.52	0.32	-0.28
Operating Cash Flow Per Share	-0.73	-0.66	0.07	-0.46	0.68	0.72		0.28	0.07	-0.75	0.94	-0.56	-0.1	-0.14	-0.18	0.74	0.36	0.66	-0.7	-0.36	0.56	0.03	-0.47	-0.69	0.7	-0.14
Capex To Depreciation	-0.67	-0.64	-0.18	-0.23	0.63	0.07	0.28		-0.18	-0.61	0.01	-0.38	-0.32	0.17	0.13	0.59	0.95	0.02	-0.3	-0.19	0.65	0.63	-0.1	-0.44	-0.22	0.25
Pb Ratio	0.0	0.0	1.0	0.04	0.0	0.14	0.07	-0.18		0.01	0.11	0.71	0.03	-0.02	-0.01	0.01	-0.13	0.14	0.03	0.08	0.01	-0.07	0.04	0.01	0.09	0.61
Ev To Sales	0.91	0.9	0.01	0.68	-0.93	-0.61	-0.75	-0.61	0.01		-0.54	0.59	0.12	0.08	0.26	-0.91	-0.66	-0.56	0.66	0.36	-0.75	-0.41	0.32	0.89	-0.13	0.17
Free Cash Flow Per Share	-0.52	-0.43	0.11	-0.34	0.46	0.74	0.94	0.01	0.11	-0.54		-0.45	-0.03	-0.23	-0.18	0.56	0.07	0.58	-0.67	-0.25	0.34	-0.27	-0.54	-0.53	0.79	-0.14
Roic	0.63	0.61	0.71	0.25	-0.63	-0.35	-0.56	-0.38	0.71	0.59	-0.45		0.34	0.1	-0.06	-0.5	-0.38	-0.5	0.36	0.46	-0.57	-0.28	0.15	0.47	-0.3	0.58
Inventory Turnover	0.47	0.47	0.03	-0.6	-0.4	0.01	-0.1	-0.32	0.03	0.12	-0.03	0.34		0.15	-0.9	0.09	-0.28	-0.36	-0.24	0.61	-0.71	-0.47	-0.27	-0.27	-0.04	-0.04
Net Income Per Share	0.2	-0.03	-0.02	-0.19	-0.01	-0.69	-0.14	0.17	-0.02	0.08	-0.23	0.1	0.15		-0.22	-0.06	0.31	-0.11	0.22	0.61	-0.1	0.25	0.25	-0.08	0.07	0.45
Days Of Inventory On Hand	-0.13	-0.07	-0.01	0.86	0.0	-0.18	-0.18	0.13	-0.01	0.26	-0.18	-0.06	-0.9	-0.22		-0.41	0.06	0.1	0.45	-0.53	0.39	0.32	0.35	0.62	-0.03	0.11
Payables Turnover	-0.79	-0.76	0.01	-0.74	0.81	0.59	0.74	0.59	0.01	-0.91	0.56	-0.5	0.09	-0.06	-0.41		0.61	0.54	-0.59	-0.28	0.6	0.37	-0.23	-0.94	0.25	-0.05
Capex To Revenue	-0.69	-0.71	-0.13	-0.34	0.69	0.0	0.36	0.95	-0.13	-0.66	0.07	-0.38	-0.28	0.31	0.06	0.61		0.16	-0.29	-0.2	0.69	0.71	-0.04	-0.51	-0.09	0.18
Cash Per Share	-0.63	-0.67	0.14	-0.21	0.69	0.41	0.66	0.02	0.14	-0.56	0.58	-0.5	-0.36	-0.11	0.1	0.54	0.16		-0.05	-0.61	0.66	0.42	0.26	-0.48	0.6	-0.25
Pocfratio	0.52	0.36	0.03	0.58	-0.41	-0.75	-0.7	-0.3	0.03	0.66	-0.67	0.36	-0.24	0.22	0.45	-0.59	-0.29	-0.05		0.01	-0.19	0.3	0.91	0.63	-0.22	0.14
Interest Coverage	0.63	0.48	0.08	-0.21	-0.49	-0.45	-0.36	-0.19	0.08	0.36	-0.25	0.46	0.61	0.61	-0.53	-0.28	-0.2	-0.61	0.01		-0.66	-0.47	-0.15	0.07	-0.17	0.45
Payout Ratio	-0.91	-0.94	0.01	-0.11	0.92	0.32	0.56	0.65	0.01	-0.75	0.34	-0.57	-0.71	-0.1	0.39	0.6	0.69	0.66	-0.19	-0.66		0.7	0.11	-0.46	0.11	-0.06
Capex To Operating Cash Flow	-0.54	-0.63	-0.07	-0.06	0.61	-0.24	0.03	0.63	-0.07	-0.41	-0.27	-0.28	-0.47	0.25	0.32	0.37	0.71	0.42	0.3	-0.47	0.7		0.58	-0.24	-0.18	0.03
Pfcf Ratio	0.21	0.01	0.04	0.32	-0.05	-0.6	-0.47	-0.1	0.04	0.32	-0.54	0.15	-0.27	0.25	0.35	-0.23	-0.04	0.26	0.91	-0.15	0.11	0.58		0.29	-0.16	0.09
Days Payables Outstanding	0.67	0.71	0.01	0.9	-0.76	-0.52	-0.69	-0.44	0.01	0.89	-0.53	0.47	-0.27	-0.08	0.62	-0.94	-0.51	-0.48	0.63	0.07	-0.46	-0.24	0.29		-0.2	0.13
Income Quality	-0.18	-0.13	0.09	-0.05	0.14	0.32	0.7	-0.22	0.09	-0.13	0.79	-0.3	-0.04	0.07	-0.03	0.25	-0.09	0.6	-0.22	-0.17	0.11	-0.18	-0.16	-0.2		-0.02
Roe	0.13	0.09	0.61	0.2	-0.12	-0.28	-0.14	0.25	0.61	0.17	-0.14	0.58	-0.04	0.45	0.11	-0.05	0.18	-0.25	0.14	0.45	-0.06	0.03	0.09	0.13	-0.02

Click cells to compare fundamentals

Surgery Partners Account Relationship Matchups

Surgery Partners fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	0.41	0.76	1.74	1.01	1.46	1.52
Ptb Ratio	2.54	12.24	3.55	1.28	2.02	2.12
Days Sales Outstanding	65.15	75.0	70.57	65.59	66.05	85.05
Free Cash Flow Yield	0.074	0.14	0.007626	0.0305	0.051	0.065
Operating Cash Flow Per Share	2.48	3.01	2.68	5.06	1.2	1.73
Stock Based Compensation To Revenue	0.00557	0.007096	0.00782	0.007246	0.006452	0.003915
Capex To Depreciation	0.96	0.45	0.58	0.7	0.75	0.53
Pb Ratio	2.54	12.24	3.55	1.28	2.02	2.12
Ev To Sales	1.95	2.31	3.04	2.05	2.51	2.96
Free Cash Flow Per Share	1.16	4.18	0.41	0.85	1.63	1.17
Roic	0.0692	(0.006154)	0.0653	0.0665	0.0799	0.058
Inventory Turnover	30.4	26.25	28.37	27.51	27.87	21.6
Net Income Per Share	(4.28)	0.95	0.0267	0.98	(0.0947)	(0.0995)
Days Of Inventory On Hand	12.01	13.91	12.86	13.27	13.1	16.36
Payables Turnover	14.56	14.77	13.88	12.96	12.2	10.41
Sales General And Administrative To Revenue	0.0484	0.0522	0.0467	0.0402	0.0441	0.066
Capex To Revenue	0.0402	0.0231	0.0259	0.0317	0.0324	0.0215
Cash Per Share	3.84	1.92	6.52	5.38	3.08	2.24
Pocfratio	5.84	5.73	44.41	16.13	13.68	17.3
Interest Coverage	1.32	1.22	1.37	1.47	1.7	1.56
Capex To Operating Cash Flow	0.57	0.17	0.66	0.51	0.3	0.27
Pfcf Ratio	13.52	6.94	131.13	32.76	19.6	23.58
Days Payables Outstanding	25.07	24.71	26.3	28.17	29.92	33.5
Income Quality	2.87	189.92	1.23	1.83	(24.69)	(23.45)
Roe	0.15	0.0112	0.0649	0.0435	(0.005988)	(0.005689)
Ev To Operating Cash Flow	27.52	17.39	77.76	32.8	23.43	39.04
Pe Ratio	16.4	1.1K	54.71	29.45	(337.68)	(320.79)
Return On Tangible Assets	0.0294	6.85E-4	0.0327	0.0348	(0.004768)	(0.005006)
Ev To Free Cash Flow	63.76	21.05	229.59	66.61	33.58	54.09
Earnings Yield	0.061	9.19E-4	0.0183	0.034	(0.002961)	(0.003109)
Net Debt To E B I T D A	8.34	10.36	7.24	5.75	5.96	11.47
Current Ratio	1.32	1.44	1.76	1.87	1.71	1.91
Tangible Book Value Per Share	(71.45)	(72.06)	(54.61)	(45.45)	(8.11)	(8.52)
Graham Number	11.51	1.19	18.17	21.51	5.81	8.88
Shareholders Equity Per Share	6.17	2.37	15.04	21.73	15.82	16.61

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Surgery Historical Financial Ratios

About Surgery Financial Ratios Analysis

Surgery Partners Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Free Cash Flow Yield

Surgery Partners fundamentals Correlations

Surgery Partners Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Surgery Partners fundamentals Accounts

Also Currently Popular

Additional Tools for Surgery Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Capex To Revenue	+ 0.95	Capex To Depreciation
Free Cash Flow Per Share	+ 0.94	Operating Cash Flow Per Share
Dividend Yield	+ 0.93	Price To Sales Ratio
Payout Ratio	+ 0.92	Book Value Per Share
Ev To Sales	+ 0.91	Price To Sales Ratio

Book Value Per Share	- 0.99	Dividend Yield
Days Payables Outstanding	- 0.94	Payables Turnover
Payout Ratio	- 0.94	Dividend Yield
Book Value Per Share	- 0.94	Price To Sales Ratio
Ev To Sales	- 0.93	Book Value Per Share
Payables Turnover	- 0.91	Ev To Sales